RecQ-Like Helicase 4 (RECQL4) Exacerbates Resistance to Oxaliplatin in Colon Adenocarcinoma via Activation of the PI3K/AKT Signaling Pathway

0
93
Researchers found RECQL4 was upregulated in colon adenocarcinoma (COAD), especially in Oxaliplatin-resistant COAD tissues and cells.
[Bioengineered]
Full Article